Search results for the GEO ID: GSE7291
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM174654
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab control 1 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma untreated K422 control cells
GSM174657
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab control 2 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma untreated K422 control cells
GSM174658
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab control 3 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma untreated K422 control cells
GSM174659
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab control 4 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma untreated K422 control cells
GSM174660
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab control 5 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma untreated K422 control cells
GSM174661
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab 100 µCi, 46 min, sample 1 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma Bi-213-CD20-Rituximab irradiated K422 cells
GSM174662
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab 100 µCi, 46 min, sample 2 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma Bi-213-CD20-Rituximab irradiated K422 cells
GSM174663
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab 100 µCi, 46 min, sample 3 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma Bi-213-CD20-Rituximab irradiated K422 cells
GSM174664
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab 100 µCi, 46 min, sample 4 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma Bi-213-CD20-Rituximab irradiated K422 cells
GSM174665
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab 100 µCi, 46 min, sample 5 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma Bi-213-CD20-Rituximab irradiated K422 cells
GSM174672
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab 100 µCi, 24 h, sample 1 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma Bi-213-CD20-Rituximab irradiated K422 cells
GSM174673
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab 100 µCi, 24 h, sample 2 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma Bi-213-CD20-Rituximab irradiated K422 cells
GSM174674
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab 100 µCi, 24 h, sample 3 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma Bi-213-CD20-Rituximab irradiated K422 cells
GSM174675
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab 100 µCi, 24 h, sample 4 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma Bi-213-CD20-Rituximab irradiated K422 cells
GSM174676
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab 100 µCi, 24 h, sample 5 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma Bi-213-CD20-Rituximab irradiated K422 cells
GSM174677
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab 200 µCi, 46 min, sample 1 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma Bi-213-CD20-Rituximab irradiated K422 cells
GSM174690
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab 200 µCi, 46 min, sample 2 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma Bi-213-CD20-Rituximab irradiated K422 cells
GSM174691
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab 200 µCi, 46 min, sample 3 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma Bi-213-CD20-Rituximab irradiated K422 cells
GSM174692
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab 200 µCi, 46 min, sample 4 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma Bi-213-CD20-Rituximab irradiated K422 cells
GSM174693
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab 200 µCi, 46 min, sample 5 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma Bi-213-CD20-Rituximab irradiated K422 cells
GSM174694
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab 200 µCi, 24 h, sample 1 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma Bi-213-CD20-Rituximab irradiated K422 cells
GSM174695
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab 200 µCi, 24 h, sample 2 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma Bi-213-CD20-Rituximab irradiated K422 cells
GSM174696
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab 200 µCi, 24 h, sample 3 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma Bi-213-CD20-Rituximab irradiated K422 cells
GSM174697
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab 200 µCi, 24 h, sample 4 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma Bi-213-CD20-Rituximab irradiated K422 cells
GSM174698
GPL201
Alpha-irradiation with the radioimmuno-conjugate Bi-213-CD20-Rituximab 200 µCi, 24 h, sample 5 Cell line Karpas 422 (K422) derived from a 73 year old woman with a B cell non-hodgkin´s lymphoma Bi-213-CD20-Rituximab irradiated K422 cells
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes